I saw a medtech company recently raise at all time lows and the stock jumped over 100% (has since settled around 50% higher) as they secured enough funds to reach FDA approval (or rejection) and other key milestones. Point is a similar situation could unfold here if they successfully raise the $10m with all future catalysts and impressive trial data so far.
Tough choice to wait for the SPP outcome or grab an initial parcel before...
CHM Price at posting:
2.7¢ Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)